DUBLIN--(BUSINESS WIRE)--The "Alpha 4 Beta 2 Neuronal Nicotinic Receptor (NNR) Agonist - Pipeline Insight, 2020" drug pipelines has been added to ResearchAndMarkets.com's offering. This report outlays ...
Synthekine has reported positive initial data from a Phase Ia/Ib trial evaluating STK-012 in first-line, programmed death-ligand 1 (PD-L1)-negative nonsquamous non-small cell lung cancer (NSCLC). In ...
When kids with ADHD need medicines to help with symptoms like hyperactivity, inattention, or impulsivity, doctors usually suggest stimulants first. But some children don’t respond well to these drugs ...
DUBLIN--(BUSINESS WIRE)--The "Beta-3 Receptors Agonist -Pipeline Insight, 2018" drug pipelines has been added to ResearchAndMarkets.com's offering. 'Beta-3 Receptors Agonist - Pipeline Insight, 2018' ...
-- STK-012 is an <ALPHA>/<BETA> biased IL-2 designed to specifically stimulate antigen activated T cells -- Results from an ongoing Phase 1a/1b to be presented at SITC -- Company will also present new ...
Beta-2 agonists are bronchodilators commonly used in the treatment of asthma and chronic obstructive pulmonary disease (COPD). Although beta-2 agonists have been associated with a reduced risk of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results